Iceland - Beta Blocking Medicine Use
Since 2014, Iceland Beta Blocking Medicine Use fell by 2.6% year on year. In 2019, the country was number 17 among other countries in Beta Blocking Medicine Use at 35.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Iceland is overtaken by Portugal, which was ranked number 16 with 38.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Denmark with 35.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany lead the ranking with 81.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 2.1% versus 2018. Lithuania, Belgium and Hungary respectively ranked number 2, 3 and 4 in this ranking. Turkey recorded the best 5 years average growth at +5% per year, while Chile witnessed the worst performance at -4.9% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 35.70 |
| 2018 | 36.90 |
| 2017 | 38.80 |
| 2016 | 39.20 |
| 2015 | 39.80 |
How does Iceland rank in Beta Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
82 | 2019 | +2.1 % | -1.6 % | View data | |
| 2 |
#2
Lithuania
|
77 | 2019 | +3.4 % | +1.6 % | View data | |
| 16 |
#16
Portugal
|
38 | 2019 | +5.0 % | +2.7 % | View data | |
| 17 |
#17
Iceland
|
36 | 2019 | -3.3 % | -2.6 % | View data | |
| 18 |
#18
Denmark
|
36 | 2019 | +0.8 % | -0.1 % | View data | |